Structure Therapeutics (GPCR) Insider Trading & Ownership

$38.94
-0.04 (-0.10%)
(As of 04/26/2024 08:52 PM ET)

There is no recent insider trading on record for Structure Therapeutics, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public.

Get GPCR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Structure Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Structure Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction
10/4/2023Thomas R. CarperU.S. Congress Member (D-DE)Sell$54.57$1,001 - $15,000
(Data available from 1/1/2013 forward)

GPCR Insider Trading Activity - Frequently Asked Questions

Which members of congress are trading Structure Therapeutics?

Thomas R. Carper (D-DE) has sold shares of Structure Therapeutics in the last year totaling $8,000.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:GPCR) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners